Arash Arashkia

Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease

Mohammad Khosravi, Maryam Abbasalipour, Jean‐Paul Concordet et al. · European Journal of Pharmacology · 2019 · 69 citations · Full text

Life Sciences, Genetics, Molecular Biology +15

T cell engineered with a novel nanobody‐based chimeric antigen receptor against VEGFR2 as a candidate for tumor immunotherapy

Fatemeh Taheri, Mahmoud Hassani, Zahra Sharifzadeh et al. · IUBMB Life · 2019 · 67 citations · Full text

Life Sciences, Immunology, Oncology +17

Construction of a chimeric antigen receptor bearing a nanobody against prostate a specific membrane antigen in prostate cancer

Mahmoud Hassani, Fatemeh Taheri, Zahra Sharifzadeh et al. · Journal of Cellular Biochemistry · 2019 · 54 citations

Life Sciences, Immunology, Oncology +17

Engineered Jurkat Cells for Targeting Prostate-Specific Membrane Antigen on Prostate Cancer Cells by Nanobody-Based Chimeric Antigen Receptor

Mahmoud Hassani, Fatemeh Taheri, Zahra Sharifzadeh et al. · Iranian Biomedical Journal · 2019 · 30 citations · Full text

Life Sciences, Biotechnology, Immunology +17

Polytope DNA Vaccine Development Against Hepatitis C Virus: A Streamlined Approach from In Silico Design to In Vitro and Primary In Vivo Analyses in BALB/c Mice

Arash Memarnejadian, Farzin Roohvand, Arash Arashkia et al. · Protein and Peptide Letters · 2009 · 28 citations

Life Sciences, Immunology, Molecular Biology +17